Gambogic Acid
CAS No. 2752-65-0
Gambogic Acid( B-Guttiferrin | Beta-Guttiferrin | Beta-Guttilactone )
Catalog No. M17464 CAS No. 2752-65-0
Gambogic Acid ( EC50=0.78-1.64 uM) activates caspases. Gambogic Acid competitively suppresses Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 50 | In Stock |
|
| 2MG | 29 | In Stock |
|
| 5MG | 46 | In Stock |
|
| 10MG | 65 | In Stock |
|
| 25MG | 104 | In Stock |
|
| 50MG | 148 | In Stock |
|
| 100MG | 219 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGambogic Acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionGambogic Acid ( EC50=0.78-1.64 uM) activates caspases. Gambogic Acid competitively suppresses Bcl-XL, Bcl-2, Bcl-W, Bcl-B, Bfl-1 and Mcl-1.
-
DescriptionGambogic acid is a xanthonoid that is derived from the brownish or orange resin from Garcinia hanburyi. This natural chemical has shown promising antitumor activity in clinical trials. Gambogic acid inhibits cell proliferation, angiogenesis and metastasis. Gambogic acid is currently in clinical trials in China.
-
In Vitro——
-
In Vivo——
-
SynonymsB-Guttiferrin | Beta-Guttiferrin | Beta-Guttilactone
-
PathwayCell Cycle/DNA Damage
-
TargetIntegrin
-
RecptorBfl-1| Mcl-1| Bcl-2| Bcl-B| Bcl-w
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number2752-65-0
-
Formula Weight628.75
-
Molecular FormulaC38H44O8
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 100 mg/mL 159.05 mM; H2O : < 0.1 mg/mL
-
SMILES[C@]123C4(OC(C2C[C@@H](C=C1C(=O)c1c(O3)c(c2c(c1O)C=CC(O2)(CCC=C(C)C)C)CC=C(C)C)C4=O)(C)C)C/C=C(/C(=O)O)\C
-
Chemical Name(Z)-4-((1S,3aR,5S,11R,14aS)-8-hydroxy-2,2,11-trimethyl-13-(3-methylbut-2-en-1-yl)-11-(4-methylpent-3-en-1-yl)-4,7-dioxo-2,3a,4,5,7,11-hexahydro-1H-1,5-methanofuro[3,2-g]pyrano[3,2-b]xanthen-3a-yl)-2-methylbut-2-enoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhai D, et al. Mol Y Ther, 2008, 7(6), 1639-1646.
molnova catalog
related products
-
Tadocizumab
Tadocizumab (C4G1) is a humanized monoclonal antibody targeting integrin αIIbβ3 with antiplatelet and antithrombotic activity that blocks the platelet αIIbβ3 integrin interac- with brinogen and bronectin, and can be used in the study of cardiovascular disease.
-
Elarofiban TFA
Elarofiban TFA (RWJ-53308 TFA) is a novel and orally active and selective GPIIb/IIIa antagonist for the study of cardiovascular disease.
-
SF0166
SF0166 is a topically administered αvβ3 integrin antagonist, inhibits integrin-ligand interactions with IC50 of 0.6 nM to 13 nM for human αvβ3, αvβ6, and αvβ8.
Cart
sales@molnova.com